Selectis Health, Inc.
GBCS
$3.10
$0.134.38%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -100.00% | -74.73% |
| Total Other Revenue | -5.16% | 5.80% | 11.50% | 12.69% | 11.91% |
| Total Revenue | -5.54% | 4.94% | 10.10% | 10.76% | 10.41% |
| Cost of Revenue | -3.85% | 4.61% | 7.91% | 4.35% | 1.88% |
| Gross Profit | -11.01% | 6.01% | 18.35% | 38.71% | 51.51% |
| SG&A Expenses | -9.87% | -5.05% | -22.36% | -15.31% | -14.95% |
| Depreciation & Amortization | -4.29% | -6.08% | -11.29% | -9.82% | -8.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.34% | 1.86% | -1.11% | -1.60% | -3.19% |
| Operating Income | 2.00% | 42.67% | 77.49% | 68.82% | 68.06% |
| Income Before Tax | 421.58% | 58.13% | 85.62% | 48.70% | 77.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 401.51% | 58.10% | 85.62% | 48.70% | 77.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 401.51% | 58.10% | 85.62% | 48.70% | 77.35% |
| EBIT | 2.00% | 42.67% | 77.49% | 68.82% | 68.06% |
| EBITDA | -1.65% | 92.22% | 104.69% | 87.07% | 84.34% |
| EPS Basic | 395.68% | 56.95% | 85.19% | 48.66% | 77.18% |
| Normalized Basic EPS | 24.23% | 58.40% | 75.64% | 59.89% | 56.15% |
| EPS Diluted | 356.92% | 57.09% | 84.37% | 48.22% | 76.80% |
| Normalized Diluted EPS | 29.22% | 58.40% | 75.64% | 59.89% | 56.15% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.10% | 0.20% | 0.31% |
| Average Diluted Shares Outstanding | 3.06% | 0.00% | 0.10% | 0.20% | 0.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |